tradingkey.logo

Helius Medical Technologies Inc

HSDT
2.780USD
-0.050-1.77%
收盘 12/26, 16:00美东报价延迟15分钟
112.03M总市值
亏损市盈率 TTM

Helius Medical Technologies Inc

2.780
-0.050-1.77%

关于 Helius Medical Technologies Inc 公司

Solana Company, formerly Helius Medical Technologies, Inc., is a digital asset treasury dedicated to acquiring Solana (SOL), created in partnership with Pantera and Summer Capital. It is focused on maximizing SOL per share by leveraging capital markets opportunities and on chain activity. It offers public market investors optimal exposure to Solana’s secular growth. It has adopted a digital asset treasury strategy focused on accumulating SOL, the native digital asset of the Solana blockchain, leveraging capital markets raises that produce consistent on-chain yield generation. It will provide access to the Solana network. Solana DAT provides access to the blockchain market to a new kind of investor. As a global capital markets onramp, HSDT channels liquidity into the Solana ecosystem, strengthening network security and fueling on chain activity, creating a virtuous cycle that delivers value back to shareholders.

Helius Medical Technologies Inc简介

公司代码HSDT
公司名称Helius Medical Technologies Inc
上市日期Jun 27, 2014
CEOAndreeff (Dane C)
员工数量21
证券类型Ordinary Share
年结日Jun 27
公司地址642 Newtown Yardley Road
城市NEWTOWN
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编18940
电话12159446100
网址https://heliusmedical.com/
公司代码HSDT
上市日期Jun 27, 2014
CEOAndreeff (Dane C)

Helius Medical Technologies Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Chief Financial Officer, Treasurer, Secretary, Director
Chief Financial Officer, Treasurer, Secretary, Director
15.00
-6.25%
Mr. Blane Walter
Mr. Blane Walter
Independent Director
Independent Director
2.00
-33.33%
Mr. Paul Buckman
Mr. Paul Buckman
Independent Director
Independent Director
2.00
--
Dr. Antonella Favit-Van Pelt, M.D., Ph.D.
Dr. Antonella Favit-Van Pelt, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Sherrie Perkins
Ms. Sherrie Perkins
Independent Director
Independent Director
--
--
Vice Adm. (Retd.) Edward M. (Ed) Straw
Vice Adm. (Retd.) Edward M. (Ed) Straw
Independent Director
Independent Director
--
--
Mr. Dane C. Andreeff
Mr. Dane C. Andreeff
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Cosmo Jiang
Mr. Cosmo Jiang
Director
Director
--
--
Dr. Joseph Chee
Dr. Joseph Chee
Executive Chairman of the Board
Executive Chairman of the Board
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Chief Financial Officer, Treasurer, Secretary, Director
Chief Financial Officer, Treasurer, Secretary, Director
15.00
-6.25%
Mr. Blane Walter
Mr. Blane Walter
Independent Director
Independent Director
2.00
-33.33%
Mr. Paul Buckman
Mr. Paul Buckman
Independent Director
Independent Director
2.00
--
Dr. Antonella Favit-Van Pelt, M.D., Ph.D.
Dr. Antonella Favit-Van Pelt, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Sherrie Perkins
Ms. Sherrie Perkins
Independent Director
Independent Director
--
--
Vice Adm. (Retd.) Edward M. (Ed) Straw
Vice Adm. (Retd.) Edward M. (Ed) Straw
Independent Director
Independent Director
--
--

收入明细

单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
由于公司未披露,未能获取相关数据
地区USD
名称
营收
占比
Canada
26.00K
60.47%
Other revenue
10.00K
23.26%
United States
7.00K
16.28%
业务
地区
由于公司未披露,未能获取相关数据

股东统计

更新时间: 11月20日 周四
更新时间: 11月20日 周四
持股股东
股东类型
持股股东
持股股东
占比
Fusion Summer Ltd
16.54%
Pantera Capital Partners LP
9.44%
Solana Rocket Holdings Ltd
9.41%
Polar Asset Management Partners Inc.
5.28%
Aristeia Capital, L.L.C.
2.64%
其他
56.70%
持股股东
持股股东
占比
Fusion Summer Ltd
16.54%
Pantera Capital Partners LP
9.44%
Solana Rocket Holdings Ltd
9.41%
Polar Asset Management Partners Inc.
5.28%
Aristeia Capital, L.L.C.
2.64%
其他
56.70%
股东类型
持股股东
占比
Corporation
25.96%
Hedge Fund
12.85%
Investment Advisor
9.87%
Investment Advisor/Hedge Fund
1.10%
Research Firm
0.06%
Individual Investor
0.02%
其他
50.14%

机构持股

更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
24
3.90M
10.09%
+3.90M
2025Q2
37
12.45K
1.83%
+11.99K
2025Q1
40
16.72K
1.11%
-2.03K
2024Q4
43
261.97K
7.03%
-14.04K
2024Q3
43
183.78K
9.58%
-95.02K
2024Q2
46
285.33K
12.75%
+168.92K
2024Q1
47
120.01K
13.52%
+4.71K
2023Q4
50
81.05K
12.51%
-44.86K
2023Q3
52
56.40K
16.69%
-20.37K
2023Q2
56
42.39K
14.78%
-10.21K
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Fusion Summer Ltd
6.83M
17.56%
+6.83M
--
Sep 18, 2025
Pantera Capital Partners LP
3.89M
9.99%
+3.89M
--
Sep 18, 2025
查看更多

持股ETF

机构名称
占比
暂无数据

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
类型
比率
Jun 27, 2025
Merger
50→1
Apr 30, 2025
Merger
15→1
Aug 16, 2023
Merger
50→1
Aug 16, 2023
Merger
50→1
Aug 16, 2023
Merger
50→1
Aug 16, 2023
Merger
50→1
公告日期
类型
比率
Jun 27, 2025
Merger
50→1
Apr 30, 2025
Merger
15→1
Aug 16, 2023
Merger
50→1
Aug 16, 2023
Merger
50→1
Aug 16, 2023
Merger
50→1
Aug 16, 2023
Merger
50→1
Dec 31, 2020
Merger
35→1
Dec 31, 2020
Merger
35→1
Dec 31, 2020
Merger
35→1
Dec 31, 2020
Merger
35→1

常见问题

Helius Medical Technologies Inc的前五大股东是谁?

Helius Medical Technologies Inc 的前五大股东如下:
Fusion Summer Ltd持有股份:6.83M,占总股份比例:17.56%。
Pantera Capital Partners LP持有股份:3.89M,占总股份比例:9.99%。

Helius Medical Technologies Inc的前三大股东类型是什么?

Helius Medical Technologies Inc 的前三大股东类型分别是:
Fusion Summer Ltd
Pantera Capital Partners LP
Solana Rocket Holdings Ltd

有多少机构持有Helius Medical Technologies Inc(HSDT)的股份?

截至2025Q3,共有24家机构持有Helius Medical Technologies Inc的股份,合计持有的股份价值约为3.90M,占公司总股份的10.09%。与2025Q2相比,机构持股有所增加,增幅为8.26%。

哪个业务部门对Helius Medical Technologies Inc的收入贡献最大?

在FY2025Q2,--业务部门对Helius Medical Technologies Inc的收入贡献最大,创收--,占总收入的--%。
KeyAI